Premenstrual dysphoric disorder: current status of treatment
Author(s) -
Francesco Bianchi-Demicheli,
Frank Lüdicke,
Hervé Lucas,
D Chardonnens
Publication year - 2002
Publication title -
schweizerische medizinische wochenschrift
Language(s) - English
Resource type - Journals
ISSN - 0036-7672
DOI - 10.4414/smw.2002.10055
Subject(s) - premenstrual dysphoric disorder , medicine , luteal phase , cochrane library , randomized controlled trial , psychiatry , ovulation , menstrual cycle , hormone
Premenstrual dysphoric disorder (PMDD), also referred to as premenstrual syndrome (PMS), is a recurrent luteal-phase condition involving regular occurrence, prior to the onset of menstrual bleeding, of a cluster of symptoms of sufficient severity to result in the deterioration of interpersonal relationships and normal activity. Several treatment options for PMDD with varying degrees of efficacy have been proposed. The literature is reviewed and treatments of proven efficacy are reported.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom